Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| duct epithelial cell | 3 studies | 21% ± 8% | |
| respiratory goblet cell | 3 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of SLC5A8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 97% | 283.67 | 86 / 89 | 66% | 25.91 | 599 / 901 |
| thymus | 100% | 2629.31 | 653 / 653 | 52% | 16.32 | 316 / 605 |
| adrenal gland | 98% | 323.50 | 254 / 258 | 14% | 2.10 | 33 / 230 |
| prostate | 79% | 187.40 | 193 / 245 | 25% | 1.19 | 123 / 502 |
| lung | 66% | 204.75 | 384 / 578 | 25% | 3.85 | 286 / 1155 |
| ovary | 72% | 146.22 | 129 / 180 | 0% | 0 | 0 / 430 |
| breast | 4% | 3.36 | 18 / 459 | 25% | 10.00 | 282 / 1118 |
| bladder | 24% | 23.19 | 5 / 21 | 3% | 0.79 | 13 / 504 |
| brain | 22% | 10.87 | 593 / 2642 | 0% | 0 | 0 / 705 |
| skin | 16% | 17.63 | 297 / 1809 | 1% | 0.02 | 4 / 472 |
| uterus | 3% | 30.85 | 5 / 170 | 6% | 1.46 | 27 / 459 |
| intestine | 5% | 12.80 | 50 / 966 | 2% | 0.14 | 13 / 527 |
| esophagus | 4% | 1.77 | 60 / 1445 | 1% | 0.02 | 1 / 183 |
| blood vessel | 4% | 3.01 | 60 / 1335 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 3% | 0.48 | 11 / 406 |
| stomach | 0% | 0.07 | 1 / 359 | 2% | 0.66 | 6 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.61 | 1 / 45 |
| pancreas | 0% | 0.61 | 1 / 328 | 2% | 0.16 | 3 / 178 |
| adipose | 2% | 0.86 | 22 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0.17 | 1 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.05 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0015730 | Biological process | propanoate transmembrane transport |
| GO_0006821 | Biological process | chloride transport |
| GO_0034356 | Biological process | NAD biosynthesis via nicotinamide riboside salvage pathway |
| GO_0006848 | Biological process | pyruvate transport |
| GO_0006811 | Biological process | monoatomic ion transport |
| GO_0015727 | Biological process | lactate transport |
| GO_0015705 | Biological process | iodide transport |
| GO_0006846 | Biological process | acetate transport |
| GO_0015706 | Biological process | nitrate transmembrane transport |
| GO_2001142 | Biological process | nicotinate transport |
| GO_0006814 | Biological process | sodium ion transport |
| GO_0006915 | Biological process | apoptotic process |
| GO_0035873 | Biological process | lactate transmembrane transport |
| GO_0016324 | Cellular component | apical plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0000811 | Cellular component | GINS complex |
| GO_0022803 | Molecular function | passive transmembrane transporter activity |
| GO_0015129 | Molecular function | lactate transmembrane transporter activity |
| GO_0005343 | Molecular function | organic acid:sodium symporter activity |
| GO_0015552 | Molecular function | propionate transmembrane transporter activity |
| GO_0008028 | Molecular function | monocarboxylic acid transmembrane transporter activity |
| GO_0140161 | Molecular function | monocarboxylate:sodium symporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC5A8 |
| Protein name | Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8) |
| Synonyms | SMCT1 SMCT AIT |
| Description | FUNCTION: Acts as an electrogenic sodium (Na(+)) and chloride (Cl-)-dependent sodium-coupled solute transporter, including transport of monocarboxylates (short-chain fatty acids including L-lactate, D-lactate, pyruvate, acetate, propionate, valerate and butyrate), mocarboxylate drugs (nicotinate, benzoate, salicylate and 5-aminosalicylate) and ketone bodies (beta-D-hydroxybutyrate, acetoacetate and alpha-ketoisocaproate), with a Na(+):substrate stoichiometry of between 4:1 and 2:1 . Catalyzes passive carrier mediated diffusion of iodide . Mediates iodide transport from the thyrocyte into the colloid lumen through the apical membrane . May be responsible for the absorption of D-lactate and monocarboxylate drugs from the intestinal tract . Acts as a tumor suppressor, suppressing colony formation in colon cancer, prostate cancer and glioma cell lines . May play a critical role in the entry of L-lactate and ketone bodies into neurons by a process driven by an electrochemical Na(+) gradient and hence contribute to the maintenance of the energy status and function of neurons . Mediates sodium-coupled electrogenic transport of pyroglutamate (5-oxo-L-proline) . Can mediate the transport of chloride, bromide, iodide and nitrate ions when the external concentration of sodium ions is reduced . . |
| Accessions | ENST00000572861.3 ENST00000536262.3 Q8N695 |